EIDOS A Mechanistic Classification of Adverse Drug Effects

被引:20
作者
Ferner, Robin E. [1 ,2 ]
Aronson, Jeffrey K. [3 ]
机构
[1] City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England
[2] Univ Birmingham, Dept Clin Pharmacol, Birmingham, W Midlands, England
[3] Dept Primary Hlth Care, Oxford, England
关键词
RECEPTORS; FLUID; DOTS; TIME;
D O I
10.2165/11318910-000000000-00000
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The mechanisms of adverse drug effects have not been adequately classified. Here, we propose a comprehensive mechanistic classification or adverse drug effects that considers five elements: the Extrinsic chemical species (E) that initiates the effect; the Intrinsic chemical species (1) that it affects; the Distribution (D) of these species in the body; the (physiological or pathological) Outcome (O); and the Sequela (S), which is the adverse effect. This classification, which we have called EIDOS, describes the mechanism by which an adverse effect Occurs; it complements the DoTS classification of adverse effects (based oil clinical pharmacology), which takes into account Dose responsiveness, Time course, and Susceptibility factors. Together, these two classification systems, mechanistic and clinical, comprehensively delineate all the important aspects of adverse drug reactions; they should contribute to areas such as drug development and regulation, pharmacovigilance, monitoring therapy, and the prevention, diagnosis, and treatment of adverse drug effects.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 49 条
[1]   AMIODARONE AND ITS DESETHYL METABOLITE - TISSUE DISTRIBUTION AND MORPHOLOGIC CHANGES DURING LONG-TERM THERAPY [J].
ADAMS, PC ;
HOLT, DW ;
STOREY, GCA ;
MORLEY, AR ;
CALLAGHAN, J ;
CAMPBELL, RWF .
CIRCULATION, 1985, 72 (05) :1064-1075
[2]   Medication errors: what they are, how they happen, and how to avoid them [J].
Aronson, J. K. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2009, 102 (08) :513-521
[3]   Drug safety - Anecdotes that provide definitive evidence [J].
Aronson, Jeffrey K. ;
Hauben, Manfred .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 333 (7581) :1267-1269
[4]   A Strategy for Regulatory Action When New Adverse Effects of a Licensed Product Emerge [J].
Aronson, Jeffrey K. ;
Price, Deirdre ;
Ferner, Robin E. .
DRUG SAFETY, 2009, 32 (02) :91-98
[5]   Clarification of terminology in drug safety [J].
Aronson, JK ;
Ferner, RE .
DRUG SAFETY, 2005, 28 (10) :851-870
[6]   Joining the DoTS: new approach to classifying adverse drug reactions [J].
Aronson, JK ;
Ferner, RE .
BRITISH MEDICAL JOURNAL, 2003, 327 (7425) :1222-1225
[7]   Critical role of c-Jun N-terminal protein kinase activation in troglitazone-induced apoptosis of human HepG2 hepatoma cells [J].
Bae, MA ;
Song, BJ .
MOLECULAR PHARMACOLOGY, 2003, 63 (02) :401-408
[8]   LEAD-POISONING FROM ASIAN TRADITIONAL REMEDIES IN THE WEST MIDLANDS - REPORT OF A SERIES OF 5 CASES [J].
BAYLY, GR ;
BRAITHWAITE, RA ;
SHEEHAN, TMT ;
DYER, NH ;
GRIMLEY, C ;
FERNER, RE .
HUMAN & EXPERIMENTAL TOXICOLOGY, 1995, 14 (01) :24-28
[9]   Outbreak of Adverse Reactions Associated with Contaminated Heparin [J].
Blossom, David B. ;
Kallen, Alexander J. ;
Patel, Priti R. ;
Elward, Alexis ;
Robinson, Luke ;
Gao, Ganpan ;
Langer, Robert ;
Perkins, Kiran M. ;
Jaeger, Jennifer L. ;
Kurkjian, Katie M. ;
Jones, Marilyn ;
Schillie, Sarah F. ;
Shehab, Nadine ;
Ketterer, Daniel ;
Venkataraman, Ganesh ;
Kishimoto, Takashi Kei ;
Shriver, Zachary ;
McMahon, Ann W. ;
Austen, K. Frank ;
Kozlowski, Steven ;
Srinivasan, Arjun ;
Turabelidze, George ;
Gould, Carolyn V. ;
Arduino, Matthew J. ;
Sasisekharan, Ram .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (25) :2674-2684
[10]   Time course of muscle atrophy and recovery following a phenol-induced nerve block [J].
BodineFowler, SC ;
Allsing, S ;
Botte, MJ .
MUSCLE & NERVE, 1996, 19 (04) :497-504